{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Marquez J"],"funding":["University of Maryland, School of Pharmacy, Mass Spectrometry Center","Division of Cancer Prevention, National Cancer Institute"],"pagination":["14381-14387"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10975668"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(12)"],"pubmed_abstract":["Prostaglandin F2 receptor negative regulator (PTGFRN) is a transmembrane protein whose expression has been previously implicated in cancer metastasis. However, the exact molecular mechanisms by which PTGFRN influences cancer progression are still unknown. As such, our laboratory set out to investigate how PTGFRN knockdown affected the expression of other proteins. We also carried out coimmunoprecipitation experiments using a monoclonal anti-PTGFRN antibody. We employed mass spectrometry-based proteomics for both experiments to identify proteins that were associated with PTGFRN. Our data show that PTGFRN knockdown increased pathways related to innate immune responses and decreased pathways associated with the synthesis of metabolic precursors and protein processing, among others. Additional"],"journal":["ACS omega"],"pubmed_title":["Effect of PTFGRN Expression on the Proteomic Profile of A431 Cells and Determination of the PTGFRN Interactome."],"pmcid":["PMC10975668"],"funding_grant_id":["R44CA162629","SOP1841-IQB2014","R44CA224718"],"pubmed_authors":["Marquez J","Kane MA","Hayashi J","Dong J","Weldemariam MM","Serrero G"],"additional_accession":[]},"is_claimable":false,"name":"Effect of PTFGRN Expression on the Proteomic Profile of A431 Cells and Determination of the PTGFRN Interactome.","description":"Prostaglandin F2 receptor negative regulator (PTGFRN) is a transmembrane protein whose expression has been previously implicated in cancer metastasis. However, the exact molecular mechanisms by which PTGFRN influences cancer progression are still unknown. As such, our laboratory set out to investigate how PTGFRN knockdown affected the expression of other proteins. We also carried out coimmunoprecipitation experiments using a monoclonal anti-PTGFRN antibody. We employed mass spectrometry-based proteomics for both experiments to identify proteins that were associated with PTGFRN. Our data show that PTGFRN knockdown increased pathways related to innate immune responses and decreased pathways associated with the synthesis of metabolic precursors and protein processing, among others. Additional","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2026-04-08T19:00:48.794Z","creation":"2025-04-06T07:46:28.188Z"},"accession":"S-EPMC10975668","cross_references":{"pubmed":["38559916"],"doi":["10.1021/acsomega.4c00042"]}}